CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,191,320
- in 3 filings, $2.1M under 10b5-1 plans
Net −$2,191,320. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-14 | LENZ BRIAN Chief Financial Officer | Purchase | +1,000 | $7.50 | $8K | 2,000 |
| 2014-05-14 | Mond James CSO/CMO | Purchase | +1,315 | $7.60 | $10K | 1,315 |
| 2013-12-10 | Grossman Jerrold B Director | Purchase | +500 | $7.30 | $4K | 575,574 |
| 2013-12-10 | Grossman Jerrold B Director | Purchase | +3,650 | $7.30 | $27K | 578,724 |
| 2013-10-22 | Burrill Capital Fund IV, L.P. 10% owner | Purchase | +308,824 | $8.50 | $2.6M | 1,433,304 |
| 2013-10-22 | LENZ BRIAN Chief Financial Officer | Purchase | +1,000 | $8.50 | $9K | 1,000 |
| 2013-10-22 | Grossman Jerrold B Director | Purchase | +11,764 | $8.50 | $100K | 507,428 |
| 2013-10-22 | Grossman Jerrold B Director | Purchase | +32,352 | $8.50 | $275K | 539,780 |
| 2013-10-22 | Grossman Jerrold B Director | Purchase | +35,294 | $8.50 | $300K | 575,074 |
| 2013-10-22 | Grossman Adam S President & CEO | Purchase | +23,529 | $8.50 | $200K | 580,957 |
| 2013-10-22 | Guiheen Lawrence P. Director | Purchase | +5,000 | $8.50 | $43K | 5,000 |
| 2013-10-22 | Aisling Capital II LP 10% owner | Purchase | +411,765 | $8.50 | $3.5M | 3,620,143 |
Page 7 of 7 · 132 trades